Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Kansas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Kansas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Kansas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Kumar Dalla (NPI 1841291903)

Field	Value
Entity Type	Individual
Organization	Kumar Dalla
Address	530 N Lorraine St
City	Wichita
State	KS
ZIP	67214
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	August 10, 2005

Payer Source	Total Paid
Medicare	$3.2M
Medicaid	$0

Key Findings

KUMAR DALLA is a retina specialist whose Medicare billing is dominated by intravitreal anti-VEGF therapy and related retina procedures, consistent with a high-volume retinal injection practice. The provider’s total Medicare revenue is $3.2M, and the three highest-revenue drug codes are J0178, J2777, and J2778, which together account for 78.5% of this provider's total Medicare revenue. This code mix (large shares for J0178, J2777, J2778 plus procedural codes like 67028 and imaging codes like 92134) signals a service-line focused on repeated intravitreal injections and retinal diagnostics rather than broad multispecialty ophthalmology care.

Revenue concentration is heavily skewed to a small set of drug codes: J0178 generated $1.4M (44.2% of Medicare revenue), J2777 produced $563.8K (17.4%), and J2778 produced $546.9K (16.9%), matching the precomputed note that the top three codes drive 78.5% of Medicare revenue. Reliance on a few high-revenue injectables makes the practice commercially concentrated around anti-VEGF treatments, which will materially affect reimbursement exposure and drug-supply economics for the provider. Monitoring utilization and unit pricing for these specific codes should capture the majority of revenue risk and opportunity.

Operational volume is evident in claim counts and average paid-per-claim for key injections: J0178 shows 2.1K claims at $692 avg paid/claim, J2777 has 19.4K claims at $29 avg paid/claim, and J2778 has 3K claims at $182 avg paid/claim. Those claim volumes indicate frequent, recurring administration encounters rather than isolated procedures, supporting a clinic workflow optimized for injections and follow-up retinal care. The pattern is consistent with a practice that manages chronic retinal conditions requiring repeated dosing.

Competitive standing versus national Medicare peers is mixed: for the top drugs J0178 and J2777 the dataset labels them as "typical, unremarkable volume for this code" (J0178 ranks #508 of 3204, 84th percentile; J2777 ranks #551 of 2039, 73th percentile), while J2778 is higher-ranked but still labeled "typical, unremarkable volume for this code" (ranks #115 of 1208, 91th percentile). In contrast, several procedural and ancillary codes are unusually high: 67028 ranks in the 95th percentile and is described as "notably above typical national volume for this code," and 92134 ranks in the 98th percentile and is described as an "extreme outlier, far above typical national volume for this code." Together these signals imply the provider is an above-typical procedural/imaging performer regionally while maintaining essentially typical national volumes for the highest-revenue drug codes.

Diagnostic and procedural intensity is elevated relative to peers: 92134 (OCT) accounts for $70.4K (2.2% of Medicare revenue) with 2.6K claims and is flagged as an "extreme outlier, far above typical national volume for this code," while 67028 (intravitreal injection procedure) brought $202.3K (6.2%) and is "notably above typical national volume for this code." High utilization of retinal imaging and injection procedures alongside concentrated drug revenue suggests a vertically integrated clinical workflow—frequent imaging to guide recurrent injections—rather than episodic surgical retina care alone.

This provider is effectively single-payer on file: Medicare accounts for $3.2M in lifetime revenue and there is no Medicaid billing on file. The absence of Medicaid activity means analysts should treat Medicaid market exposure as nil in this dataset and focus competitive and utilization comparisons to other Medicare-focused retina practices; conclusions about Medicaid patient access or payer negotiation leverage cannot be drawn from this record.

Ambulatory encounter patterns complement the injection-heavy profile: 99213 shows 628 claims and $34.5K (1.1% of Medicare revenue) and is labeled "notably above typical national volume for this code" (96th percentile), and 99204 appears with 133 claims and $14.4K (0.4%) at a 94th percentile rank for new patient visits. These E/M volumes indicate active follow-up and new patient intake in clinic, supporting a stable referral stream feeding the injection and imaging workload.

The provider has long tenure in the Medicare program, with an NPI enumeration date of 2005-08-10 (~21 years ago), which, combined with $3.2M in Medicare lifetime revenue, points to an established retina practice. Longevity plus concentrated, high-frequency service lines (injections and OCT) suggest operational maturity and predictable revenue drivers, making this profile useful for benchmarking injectables spending and imaging utilization in market-level analyses.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

22 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,070	$690	$1.4M
J2777	Injection, faricimab‑svoa, 0.1 mg	19,440	$30	$563.8K
J2778	Injection, ranibizumab, 0.1 mg	3,010	$180	$546.9K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,380	$90	$202.3K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	720	$220	$159.7K
J3490	Unclassified drugs	40	$1,840	$77.4K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,610	$30	$70.4K
J3590	Unclassified biologics	680	$70	$49K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	630	$60	$34.5K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	180	$160	$29.1K

Showing 1–10 of 22

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Kansas Distribution

Kumar Dalla — 4 of 22 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Kansas

Full comparison — all codes billed, vs. state median

22 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	9	30	1,770	$690	$1.3M
J2777	7	30	12,060	$30	$575.7K
J2778	3	20	860	$180	$297.6K
67028	6	40	1,170	$90	$111.4K
Q5128	1	10	290	$220	$83.5K
J7312	9	10	260	$160	$43.6K
67108	5	20	20	$1,130	$24.8K
J3590	1	20	200	$100	$24.1K
J3490	15	20	120	$200	$23.4K
67041	9	10	20	$970	$21.4K

Showing 1–10 of 22

Related Providers

Other providers that share a Tax Identification Number (TIN) with Kumar Dalla, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
David Dyer	KS	Ophthalmology Physician	$7.5M	$0
Bassam Mattar	KS	Hematology & Oncology Physician	$7.2M	$0
Pavan Reddy	KS	Hematology & Oncology Physician	$6.7M	$0
Jeremy Deutsch	KS	Hematology & Oncology Physician	$5.7M	$0
Thomas Finley	OK	Ophthalmology Physician	$4.8M	$0
Daniel Feiler	KS	Ophthalmology Physician	$4.8M	$0
Travis Koeneke	KS	Hematology & Oncology Physician	$4.4M	$0
Christopher Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0
Stephen Wiles	MO	Ophthalmology Physician	$4.4M	$0
Shaker Dakhil	KS	Hematology & Oncology Physician	$4.4M	$0

Nearby Providers

Other providers in the same ZIP code as Kumar Dalla, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Craig Resources LLC	KS	Home Health Agency	$0	$97.3M
Paradigm Services Inc	KS	Intellectual and/or Developmental Disabilities Residential Treatment Facility	$0	$42.4M
Wesley Medical Center LLC	KS	General Acute Care Hospital	$0	$30.2M
Gracemed Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$18.3M
Healthcore Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$15.3M
Diversified Family Services LLC	KS	Home Health Agency	$0	$13.9M
Alpha Service	KS	Developmentally Disabled Services Day Training Agency	$0	$12.1M
Carepoint Emergency Medicine Kansas LLC	KS	Emergency Medicine Physician	$0	$11.8M
Hunter Health Clinic Inc	KS	Federally Qualified Health Center (FQHC)	$0	$10.4M
Ascension Via Christi Hospitals Wichita Inc.	KS	General Acute Care Hospital	$0	$8.9M

Kumar Dalla — Billing Profile & Reimbursement Data

Sign up for Kumar Dalla — Billing Profile & Reimbursement Data policy alerts

Kumar Dalla — Billing Profile & Reimbursement Data

Sign up for Kumar Dalla — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References